Laurence Turka

Laurence Turka

Företagsledare/Principal på
Immune Tolerance Network
68 år
Commercial Services
Health Technology
Consumer Services

Profil

Laurence Turka is the founder of Rheos Medicines, Inc. which was founded in 2018.
He is currently the Deputy Director at Immune Tolerance Network.
He is also a Member of the Association of American Physicians since 2003 and a Member of the American Society for Clinical Investigation since 1995.
Dr. Turka has held several former positions including Chairman-Scientific Counselors at the National Institute of Allergy & Infectious Diseases, President at The American Society of Transplantation, Professor at Harvard Medical School, and Editor in Chief at The Journal of Clinical Investigation.
Dr. Turka received his doctorate degree from Yale School of Medicine.
Additionally, Dr. Turka was the Chief Scientific Officer & Head-Research at Rubius Therapeutics, Inc. from 2021 to 2023.

Aktiva positioner av Laurence Turka

FöretagPositionStart
Företagsledare/Principal -
Företagsledare/Principal 1995-01-01
Företagsledare/Principal 2003-01-01

Tidigare kända positioner av Laurence Turka

FöretagPositionSlut
RUBIUS THERAPEUTICS Teknisk/Vetenskaplig/F&U Direktör 2023-01-31
Grundare 2020-01-01
Företagsledare/Principal -
Företagsledare/Principal -
President -
Se detaljerna i Laurence Turkas erfarenhet

Laurence Turkas utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

49

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Commercial Services

Health Technology

Government

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Laurence Turka